Satish Modi is an Ophthalmology physician affiliated with Albert Einstein College of Medicine. OpenAlex indexes 33 publications with 686 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
23 Davis Avenue
Poughkeepsie, NY 12603
Telephone
845-454-1025Registry record last updated 8 Jul 2007.
Clinical trials
- Prospective Evaluation and Comparison of Bilateral Synergy Implants and Bilateral PanOptix Implants
Sponsor: Alterman, Modi, & Wolter Ophthalmic Physicians & Surgeons
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
36 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year202527 payments$10,957openpaymentsdata.cms.gov ↗
- Bausch & Lomb Americas Inc.Program year20255 payments
- RxSight IncProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
71.6%Corticosteroid23.1%Prednisolone Acetate100%Part D≥169 patientsProstaglandin Analog17.8%Latanoprost55%Lumigan26%Travoprost20%Part D<11 patients+ 4 more classes in this area
Musculoskeletal
23.6%Cyclooxygenase Inhibitor23.6%Ketorolac Tromethamine100%Part D≥170 patientsCardiovascular
3.8%Beta blocker3.8%Timolol Maleate100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparison of visual function and patient-reported outcomes between two full range of field intraocular lenses: a randomized controlled study
Journal of Cataract & Refractive Surgery
2025 - Clinical Comparison of a Small-Aperture Intraocular Lens Versus a Monofocal Control
Journal of Refractive Surgery
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Lipton, MD
Albert Einstein College of Medicine
Marina Konopleva, MD, PhD
Albert Einstein College of Medicine
Solomon Moshe, MD
Albert Einstein College of Medicine
Shlomo Shinnar, MD, PhD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”